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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j idThe weekly epidemiological record of the World Health
Organisation 15th May 20151 states that ‘the cases of Middle East
Respiratory Syndrome (MERS) recently exported to other countries
have not resulted in sustained onward transmission to persons
in close contact with these cases on aircraft or in the respective
countries outside the Middle East.’ This situation has changed
rapidly and remarkably. Five days after the publication of this
report, the ﬁrst case of a MERS-coronavirus (MERS-CoV) infection
in Seoul, South Korea was reported on 20 May 20152. This patient
had a history of recent travel to the Middle East. Over the ensuing
three weeks, the number of secondary, tertiary and perhaps
quaternary cases of MERS from this single patient rose rapidly and
has become the largest case cluster of MERS occurring outside the
Middle East. The Korean outbreak appears from the available data
to be attributable to poor infection control measures, although the
hospital air-conditioning system’s lack of ventilators may have
resulted in the rapid extensive spread of MERS among patients and
staff3. Furthermore, MERS-CoV was detected in bathrooms and on
doorknobs indicating ineffective disinfection procedures.
As of June 9th 2015, there have been 95 cases (with 7 deaths)
of MERS-CoV infection associated with the South Korean
outbreak3. Over two thirds of all conﬁrmed cases have been
reported from St. Mary’s Hospital, a 400 bed facility in Gyeonggi
Province, Seoul and at least 14 facilities have reported MERS cases
during the outbreak. This unusually large number of secondary
(80 cases) and tertiary (14 cases) associated with an imported case
of MERS by a traveller is a signiﬁcant development (as per 11th
June 2015). Furthermore, whilst the Korea outbreak has focussed
global attention, a nosocomial outbreak of MERS in Hufoof, Saudi
Arabia has been on going since 20 Apr 2015 and resulted in
26 cases over the past 3 weeks4. There continue to be MERS cases
reported from Jeddah and Riyadh, which are ‘‘sporadic’’ commu-
nity cases. To date Saudi Arabia has reported 1026 MERS cases
including 450 deaths (44 percent) since the ﬁrst MERS case was
reported in September, 2012.
The South Korean and Hufoof outbreaks raise several important
concerns:
First the Korean outbreak emphasizes that MERS-CoV remains a
major threat to global health security and could have epidemic
potential with time, even in the absence of virus mutation.
Second the nature of the virus and its evolution into a more
virulent form continues to need close monitoring. Genomic
sequencing studies of MERS-CoV obtained from the ﬁrst Koreanhttp://dx.doi.org/10.1016/j.ijid.2015.06.004
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creativecommons.org/licenses/by-nc-nd/4.0/).case published by the Chinese Center for Disease Control and
Prevention5 has shown homology with MERS-CoV strains
originating from Saudi Arabia. Whilst no signiﬁcant variation
has been identiﬁed it remains crucial that genomic studies for
as many MERS cases as possible are performed.
Third, up to a million pilgrims from over 182 countries will
travel to Mecca, Saudi Arabia for the Ramadan period which
begins on June 18th 2015 and the threat of further global spread
remains.
Fourth, for the past 18 months, MERS and other global infectious
diseases threats were totally overshadowed by the Ebola virus
disease epidemic6, highlighting the inadequacies of global
surveillance systems to focus concurrently on several emerging
and re-emerging infectious diseases simultaneously.
Fifth, many basic questions about the epidemiology, pathogen-
esis and management of MERS-CoV remain to be answered8.
Sixth, it’s been 3 years since MERS was identiﬁed as a lethal new
viral respiratory infection of humans9 and primary cases of
MERS-CoV infection continue to occur throughout the year7 in
the Middle East. The South Korean outbreak now illustrates the
need to enhance MERS-CoV surveillance systems, and height-
ens global awareness of MERS and the importance of infection
control measures.
Finally, the Korean outbreak emphasizes the importance of
individuals, especially healthcare workers, recognizing that
they may have been exposed to MERS patients and seeking
medical care and self-quarantining at an early time during the
disease course.
Moving forward, it is critical that global efforts are focussed
urgently on the basic science and on clinical and public health
research so that the exact mode of transmission to and between
humans, and new drugs and other therapeutic interventions and
vaccines can be developed6,7. Two coronaviruses, SARS-CoV and
now MERS-CoV, which cause severe respiratory disease with high
mortality rates emerged within the past two decades10, reinforcing
the need for clinically efﬁcacious antivirals targeting corona-
viruses. Lessons learnt from the recent Ebola Virus Disease could
also be applied to MERS11. Whilst MERS does not yet constitute an
International Public Health Emergency the Korean outbreak is an
extraordinary event. Previous estimates of the epidemic potential
of MERS-CoV have not found that it had pandemic potential12,
suggesting that airborne, human-to-human transmission is rare,
but the present outbreak indicates that simple hygiene isious Diseases. This is an open access article under the CC BY-NC-ND license (http://
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arrived at a health care system that was able to identify MERS as
a risk given his travel itinerary and had the laboratory resources
to rapidly identify the virus.
With continuing spread of MERS-CoV to countries outside the
Middle East and to all continents, MERS remains a public health
risk and possible consequences of further international spread
could be serious in view of the patterns of nosocomial transmission
within healthcare facilities. Further spread to countries with weak
health systems and laboratory facilities unable to rapidly identify
an unexpected virus may result in a widespread outbreak or an
epidemic in many of the 182 countries from which Ramadan, Hajj
and Umrah pilgrims originate.
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